NEW YORK (GenomeWeb News) — Biomarker profiling company HistoRx said yesterday that the University of California at Los Angeles has installed its image-analysis tool.
The New Haven, Conn.-based company said UCLA will use the PM-2000 system at its Biomarker Innovation Laboratory to develop in situ diagnostic assays.
Financial terms of the deal were not disclosed.
The PM-2000 employs HistoRx’s automated quantitative analysis technology to measure protein biomarkers in tissue and in tissue microarrays.
The company said the technology was developed at Yale University’s medical school and is being used through a corporate/academic research program at nine cancer and pathology research centers.
Yale researcher David Rimm, who developed the quantitative analysis technology, co-founded HistoRx and also serves as the company’s chief of medical affairs.